Strides

Our pioneering initiatives have delivered consistently for our shareholders.

Shareholder Information

Our experience has enabled us to foresee emerging trends, successfully execute strategies and deliver on stakeholder aspirations.

Vision and Mission

Headquartered in India, Strides Pharma Science Limited is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world's largest manufacturers of soft gelatin capsules.

With world-class manufacturing facilities, an innovative R&D hub in Bangalore and a robust commercial platform to market products globally, Strides has earned a reputation for building and scaling profitable businesses in a short span of time.

Read More

Attention Shareholders - holding shares in physical form

30 May/23	Annual Secretarial Compliance Report for the year ended March 31, 2023
25 May/23	Disclosure of Related Party Transactions for the half year ended March 31, 2023
25 May/23	Grant of Options under Strides ESOP Plan 2016
25 May/23	Strides reports strong Q4FY23 results and lays the foundation for a promising FY24
25 May/23	Outcome of Board Meeting - Audited Financial Results (Standalone & Consolidated) for quarter and year ended March 31, 2023
24 May/23	Newspaper Adv - Notice for transferring of equity shares to IEPF
19 May/23	Strides Puducherry facility receives Establishment Inspection Report (EIR) from USFDA confirming the reclassification of the site from Official Action Indicated (OAI) to Voluntary Action Indicated (VAI)
18 May/23	Intimation of Board Meeting scheduled on May 25, 2023
03 May/23	Strides and Orbicular enter into a strategic partnership to jointly develop a range of nasal sprays
Read More

30